Ceramide synthesis inhibitors prevent lipid-induced insulin resistance through the DAG-PKCε-insulin receptorT1150 phosphorylation pathway

Summary: Inhibition of the ceramide synthetic pathway with myriocin or an antisense oligonucleotide (ASO) targeting dihydroceramide desaturase (DES1) both improved hepatic insulin sensitivity in rats fed either a saturated or unsaturated fat diet and was associated with reductions in both hepatic ce...

Full description

Bibliographic Details
Published in:Cell Reports
Main Authors: Weiwei Xu, Dongyan Zhang, Yumin Ma, Rafael C. Gaspar, Mario Kahn, Ali Nasiri, Sue Murray, Varman T. Samuel, Gerald I. Shulman
Format: Article
Language:English
Published: Elsevier 2024-10-01
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124724010970